bromocriptine has been researched along with Precancerous Conditions in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, T; Nagasawa, H | 1 |
| Brown, CK; Goodrich-Smith, M; Johnson, D; Mackie, D; Welsch, CW | 1 |
| Bridges, RS; Ho, SM; Lane, KE; Leav, I; Rand, WM; Ziar, J | 1 |
| Anderson, TM; Brooks, CL; Brown, CK; Denenberg, B; Goodrich-Smith, M; Van, J; Welsch, CW | 1 |
| Gullino, PM | 1 |
| Medina, D | 1 |
| Hassett, CC; Lambrecht, LK; Welsch, CW | 1 |
| Welsch, CW | 2 |
| Heppner, GH; Loeffler, DA; Tsai, SJ | 1 |
| Fujimoto, NA; Ito, A; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Wada, S | 1 |
11 other study(ies) available for bromocriptine and Precancerous Conditions
| Article | Year |
|---|---|
Alteration of the development of mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN mice by different schedules of treatment with CB-154.
Topics: Age Factors; Animals; Breast; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Endometriosis; Female; Hyperplasia; Mice; Mice, Inbred Strains; Precancerous Conditions; Time Factors; Uterine Neoplasms; Uterus | 1984 |
2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Rats; Rats, Inbred Strains; Tamoxifen; Time Factors | 1982 |
Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
Topics: Animals; Bromocriptine; Estrogen Antagonists; Immunohistochemistry; Male; Precancerous Conditions; Prolactin; Proliferating Cell Nuclear Antigen; Prostate; Rats; Receptors, Estrogen; Testosterone | 1997 |
Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Prolactin; Rats; Time Factors | 1979 |
Considerations on the preneoplastic lesions of the mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane | 1977 |
Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Ovary; Precancerous Conditions; Pyrrolidines; Receptors, Androgen; Receptors, Estrogen; Testosterone; Transplantation, Isogeneic | 1977 |
Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Topics: Adrenal Glands; Animals; Bromocriptine; Castration; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Precancerous Conditions; Prolactin | 1977 |
Prolactin and the development and progression of early neoplastic mammary gland lesions.
Topics: Animals; Breast Neoplasms; Bromocriptine; Castration; DNA, Neoplasm; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Mestranol; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Norethynodrel; Organ Culture Techniques; Ovary; Parity; Placental Lactogen; Precancerous Conditions; Pregnancy; Prolactin; Transplantation, Heterologous | 1978 |
Prophylaxis of early preneoplastic lesions of the mammary gland.
Topics: Animals; Bromocriptine; Ergolines; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metergoline; Mice; Mice, Inbred C3H; Parity; Precancerous Conditions; Prolactin | 1976 |
Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Topics: Animals; Bromocriptine; Drug Administration Schedule; Hyperplasia; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Precancerous Conditions; Prolactin | 1992 |
Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Bromocriptine; Carcinogens; Carcinoma; Cocarcinogenesis; Male; Neoplasm Metastasis; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Precancerous Conditions; Prolactin; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles | 1990 |